~Company invested for the future in 2023, with 2024 positive EBITDA goal remaining intact~
Fiscal Year 2023 Highlights Include:
- Annual revenue of
$57.8 million ; - Gross profit of
$12.4 million , Gross Margin1 before amortization of$14.4 million (25% of revenue); - Operating loss of
$13.2 million ; - Adjusted EBITDA2 loss of
$10.0 million ; - Net loss and comprehensive loss of
$29.4 million , including an impairment of intangible assets and goodwill charge of$14.4 million taken in the fourth quarter of 2023; - The Company announced
$42.5 million in new system sale contract wins including a$35.3 million contract award in Q4 with a leading environmental services company inBrazil that is investing in a portfolio of landfill assets across the country to produce biomethane; - The Company launched its new sector-focused Cascade product lines; a portfolio of optimized solutions for the RNG industry; and
- The Company entered into a collaborative agreement with ZEG Biogás e
Energia SA to locally produce, market and sell one of Greenlane's largest and most popular biogas upgrading products (Totara+ water wash system) inBrazil . The agreement established a first-of-its-kind royalty-like revenue agreement for Greenlane.
Fourth Quarter Highlights Include:
- Revenue of
$17.3 million ; - Gross profit of
$2.8 million , Gross Margin1 before amortization of$3.2 million (18% of revenue); - Operating loss of
$3.0 million ; - Adjusted EBITDA2 loss of
$2.3 million ; - Net loss and comprehensive loss of
$17.7 million , including an impairment of intangible assets and goodwill charge of$14.4 million ; - Sales Order Backlog3 of
$36.0 million as atDecember 31, 2023 ; and - Cash and cash equivalents of
$11.8 million and no debt, other than payables, advance payment / performance bonding and standby letters of credit resulting from normal course operations, as atDecember 31, 2023 .
Three Months Ended Dec 31 | Twelve Months Ended | |||||
(in millions, except as noted) | 2023 | 2022 | % Change | 2023 | 2022 | % Change |
Revenue | 2 % | (19 %) | ||||
Gross Margin1 before amortization | (4 %) | (14 %) | ||||
Gross Margin as % of revenue | 18 % | 19 % | 25 % | 24 % | ||
Gross profit | (12 %) | (17 %) | ||||
Adjusted EBITDA2 | ( | ( | (17 %) | ( | ( | (410 %) |
Net loss and comprehensive loss | ( | ( | (1087 %) | ( | ( | (384 %) |
Sales Order Backlog3 | 30 % | |||||
Cash & cash equivalents | (45 %) |
"In 2023, our focus was on preparing the business for further growth, scaling and positive Adjusted EBITDA in 2024," declared
"Focusing on the fourth quarter of 2023, gross margins were lower, largely associated with three of the Company's active projects that experienced additional commissioning and other costs," noted
"The RNG market is maturing, and customers are becoming more sophisticated, shifting toward both larger projects and larger portfolios of projects and this is influencing how we are orienting our business model going forward. Our sales funnel is robust, giving us confidence in our approach, and we are particularly excited about
The Market Outlook
For the first time in the
The
In February, the
Conference Call
The public is invited to listen to the conference call in real time by telephone. To access the conference call by telephone, please dial: 1-800-319-4610 (
Shortly after the conference call, the replay will be archived on the
SPECIFIED FINANCIAL MEASURES
Management evaluates the Company's performance using a variety of measures, including "Gross Margin before amortization", "Adjusted EBITDA" and "Sales Order Backlog". The specified financial measures, including non-IFRS measures and supplementary financial measures should not be considered as an alternative to or more meaningful than revenue, gross profit or net income. These measures do not have a standardized meaning prescribed by IFRS and therefore they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS. The Company believes these specified financial measures provide useful information to both management and investors in measuring the financial performance and financial condition of the Company. Management uses these specified financial measures to exclude the impact of certain expenses and income that must be recognized under IFRS when analyzing consolidated underlying operating performance, as the excluded items are not necessarily reflective of the Company's underlying operating performance and make comparisons of underlying financial performance between periods difficult. From time to time, the Company may exclude additional items if it believes doing so would result in a more effective analysis of underlying operating performance. The exclusion of certain items does not imply that they are non-recurring.
Note 1 - Gross Margin before amortization is a non-IFRS measure and is defined by the Company as gross profit before amortization of intangible assets and property and equipment.
Note 2 - Adjusted EBITDA is a non-IFRS measure and is defined by the Company as earnings before interest, taxes, foreign exchange, depreciation and amortization, as well as adjustments for other income (expense), value assigned to options and RSU's granted, strategic initiatives, transaction costs and non-recurring items.
Reconciliation of net loss and comprehensive loss to Adjusted EBITDA:
(in $000s) | Three months ended | Twelve months ended | ||
2023 | 2022 | 2023 | 2022 | |
Net loss and comprehensive loss | (17,679) | (1,490) | (29,355) | (6,062) |
Add (deduct): | ||||
Exchange difference on translating foreign operations | (134) | (347) | (225) | 557 |
Provisions for income taxes | 485 | (136) | 1,102 | 16 |
Foreign exchange (gain) loss | (39) | (853) | 256 | (2,167) |
Other loss (income) | 111 | 37 | 172 | 37 |
Finance income | (139) | (279) | (651) | (359) |
Finance expense | 34 | 40 | 84 | 109 |
Impairment of goodwill and intangible assets | 14,352 | - | 14,352 | - |
Impairment of notes receivable | - | - | 1,068 | - |
Strategic initiatives | - | 418 | - | 1,592 |
Share-based compensation | 196 | 421 | 775 | 1,977 |
Amortization of office equipment | 107 | 79 | 435 | 447 |
Amortization of property and equipment | 47 | 68 | 175 | 146 |
Amortization of intangible assets | 336 | 58 | 1,775 | 1,736 |
Adjusted EBITDA | (2,323) | (1,984) | (10,037) | (1,968) |
Note 3 - Greenlane provides regular updates on its upgrader system sales opportunities that successfully convert into contractual agreements in its reported sales order backlog ("Sales Order Backlog"). Sales Order Backlog is a supplementary financial measure that refers to the balance of unrecognized revenue from contracted biogas upgrading system supply projects. The Company's Sales Order Backlog is a snapshot in time which varies from period-to-period. The Sales Order Backlog increases by the value of new system sales contracts and is drawn down over time as projects progress towards completion with amounts recognized in revenue (by reference to the stage of completion of each contract). A typical biogas upgrading system sales contract has six stages of completion and a duration of nine to 24 months, and therefore annual and quarterly operating results will fluctuate as a result of the timing of contract related work. Note that Sales Order Backlog does not include Cascade H2S sales, service revenue, or revenue from the Company's agreement with ZEG Biogás.
Greenlane is driving change: accelerating the energy transition to a net-zero emissions economy. We are cleaning up two of the largest and most difficult to decarbonize sectors of the global energy system: the natural gas grid and commercial transportation. As a pioneer and leading specialist in biogas upgrading, we have been actively contributing to the decarbonization of our planet for over 35 years. The systems we provide transform biogas generated from organic waste into high-value grid-ready renewable natural gas ("RNG"). Our systems produce clean, low-carbon and carbon-negative RNG from organic waste sources including agriculture (such as dairy and hog manure), water resource recovery facilities, food waste, landfills, and sugar mills. Greenlane is the only biogas upgrading company offering and actively deploying the three main upgrading technologies: waterwash, pressure swing adsorption, and membrane separation, plus proprietary biogas desulfurization technology. Greenlane has delivered over 145 biogas upgrading systems into 19 countries, including some of the largest RNG production facilities in the world, and over 160 biogas desulfurization units. For further information, please visit www.greenlanerenewables.com.
Forward Looking Information Advisory –
This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "could", "plan", or "is/are expected to", "goal", "objectives", "future", "shifting toward", "potential", "proposed", "estimate", "believe", "continues to", "remains" or "continually" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen or that current events or conditions will continue, be ongoing or be repeated such as "are transitioning" or "are realigning". The forward-looking information contained in this press release, includes, but is not limited to: that the Company is continuing to build its business foundation and is transitioning from an engineered-to-order to a configured-to-order business model; that the Company is realigning its cost structure and focusing on efficiency in supply chain execution; that it has a goal of achieving positive Adjusted EBITDA in 2023 and maintaining cash reserves; that the Company's sales funnel is robust and it has a strong future; that the RNG market is maturing and is shifting towards larger projects within larger portfolios of projects; that the agreement with ZEG Biogás will provide royalty-like revenue together with service contracts; management's expectations for regulatory developments in the US that support RNG demand including that the
FINANCIAL OUTLOOK INFORMATION – This news release contains "financial outlook information" regarding Greenlane's prospective revenue and results, which is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above. Revenue and other estimates contained in this news release were made by Greenlane management as of the date of this news release and are provided for the purpose of describing anticipated changes, and are not an estimate of profitability or any other measure of financial performance. Investors are cautioned that the financial outlook information contained in this news release should not be used for purposes other than for which it is disclosed herein. The Company's revenues are largely derived from a relatively small number of biogas upgrader orders accounted for on a stage of completion basis over typically a nine to eighteen-month period. Timing of new contract awards varies due to customer-related factors such as finalizing technical specifications and securing project funding, permits and RNG off-take and feedstock agreements. Some contracts contain termination provisions that allow the customer to terminate with no penalty or with minimum prescribed threshold payments based on the length of time since the contract was entered into. Some projects have built-in pause periods to allow customers to complete concurrent activities such as civil work. As a result, the Company's revenue varies from month to month and quarter-to-quarter. THE COMPANY QUALIFIES ALL THE FORWARD LOOKING STATEMENTS AND FINANCIAL OUTLOOK INFORMATION CONTAINED IN THIS NEWS RELEASE BY THE FOREGOING CAUTIONARY STATEMENTS.
Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this news release.
SOURCE
© Canada Newswire, source